Expansion and engraftment of stem cells using Notch 1 and/or Notch 2 agonists
AssigneeFred Hutchinson Cancer Research Center
InventorIrwin D. Bernstein
Life of this patent
Estimating the term…
Loading patent…
AssigneeFred Hutchinson Cancer Research Center
InventorIrwin D. Bernstein
Estimating the term…
The present disclosure provides methods for immortalizing precursor cells that are non-terminally differentiated cells such as stem cells, the methods comprising culturing the precursor cells in the presence of a Notch 1 agonist, Notch 2 agonist or Notch 1 agonist and Notch 2 agonist (and, in particular embodiments, one or more growth factors) that support the proliferation but not differentiation of the non-terminally differentiated cells. The present disclosure further provides methods to induce the differentiation of immortalized cells, comprising growing the cells in the presence of a Notch 1 agonist, Notch 2 agonist or Notch 1 agonist and Notch 2 agonist and at least one growth factor which supports the differentiation of the cell into a more specialized cell type. The immortalized and/or differentiated cells of the disclosure can be used to repopulate cell populations that have been diminished, for example as a result of infection or exposure to certain drugs. The disclosure further provides a cell culture comprising a population of non-terminally differentiated cells immortalized by the methods of the present disclosure and kits comprising reagents that promote the immortalization of precursor cells.
A method for expanding hematopoietic stem/progenitor cells, comprising culturing the hematopoietic stem/progenitor cells in the presence of
A method for expanding hematopoietic stem/progenitor cells, comprising culturing the hematopoietic stem/progenitor cells in the presence of
Dependencies are inferred from the claim text.